메뉴 건너뛰기




Volumn 87, Issue 10, 2013, Pages 5424-5436

Conformational epitope consisting of the V3 and V4 loops as a target for potent and broad neutralization of simian immunodeficiency viruses

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN LAMBDA CHAIN; NEUTRALIZING ANTIBODY; VIRUS PROTEIN;

EID: 84877336116     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00201-13     Document Type: Article
Times cited : (24)

References (84)
  • 1
    • 0032905728 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma
    • Igarashi T, Brown C, Azadegan A, Haigwood N, Dimitrov D, Martin MA, Shibata R. 1999. Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma. Nat. Med. 5:211-216.
    • (1999) Nat. Med. , vol.5 , pp. 211-216
    • Igarashi, T.1    Brown, C.2    Azadegan, A.3    Haigwood, N.4    Dimitrov, D.5    Martin, M.A.6    Shibata, R.7
  • 2
    • 0032907674 scopus 로고    scopus 로고
    • Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys
    • Shibata R, Igarashi T, Haigwood N, Buckler-White A, Ogert R, Ross W, Willey R, Cho MW, Martin MA. 1999. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med. 5:204 -210.
    • (1999) Nat. Med. , vol.5 , pp. 204-210
    • Shibata, R.1    Igarashi, T.2    Haigwood, N.3    Buckler-White, A.4    Ogert, R.5    Ross, W.6    Willey, R.7    Cho, M.W.8    Martin, M.A.9
  • 4
    • 67249131966 scopus 로고    scopus 로고
    • Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers
    • doi:10.1371/journal.ppat.1000433.
    • Hessell AJ, Rakasz EG, Poignard P, Hangartner L, Landucci G, Forthal DN, Koff WC, Watkins DI, Burton DR. 2009. Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. PLoS Pathog. 5:e1000433. doi:10.1371/journal.ppat.1000433.
    • (2009) PLoS Pathog. , vol.5
    • Hessell, A.J.1    Rakasz, E.G.2    Poignard, P.3    Hangartner, L.4    Landucci, G.5    Forthal, D.N.6    Koff, W.C.7    Watkins, D.I.8    Burton, D.R.9
  • 6
    • 66149094305 scopus 로고    scopus 로고
    • Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4 T-cell loss and higher titers of neutralizing antibody
    • Ourmanov I, Kuwata T, Goeken R, Goldstein S, Iyengar R, Buckler- White A, Lafont B, Hirsch VM. 2009. Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4 T-cell loss and higher titers of neutralizing antibody. J. Virol. 83:5388 -5400.
    • (2009) J. Virol. , vol.83 , pp. 5388-5400
    • Ourmanov, I.1    Kuwata, T.2    Goeken, R.3    Goldstein, S.4    Iyengar, R.5    Buckler-White, A.6    Lafont, B.7    Hirsch, V.M.8
  • 9
    • 33846964896 scopus 로고    scopus 로고
    • HIV-1 vaccine development: progress and prospects
    • Thorner AR, Barouch DH. 2007. HIV-1 vaccine development: progress and prospects. Curr. Infect. Dis. Rep. 9:71-75.
    • (2007) Curr. Infect. Dis. Rep. , vol.9 , pp. 71-75
    • Thorner, A.R.1    Barouch, D.H.2
  • 11
    • 84863774072 scopus 로고    scopus 로고
    • Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses
    • Burton DR, Poignard P, Stanfield RL, Wilson IA. 2012. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 337:183-186.
    • (2012) Science , vol.337 , pp. 183-186
    • Burton, D.R.1    Poignard, P.2    Stanfield, R.L.3    Wilson, I.A.4
  • 12
    • 0030985017 scopus 로고    scopus 로고
    • Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. AIDS Clinical Trials Group Antibody Selection Working Group.
    • D'Souza MP, Livnat D, Bradac JA, Bridges SH. 1997. Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. AIDS Clinical Trials Group Antibody Selection Working Group. J. Infect. Dis. 175:1056 -1062.
    • (1997) J. Infect. Dis. , vol.175 , pp. 1056-1062
    • D'Souza, M.P.1    Livnat, D.2    Bradac, J.A.3    Bridges, S.H.4
  • 20
    • 84870317596 scopus 로고    scopus 로고
    • Structure and design of broadlyneutralizing antibodies against HIV
    • Ryu SE, Hendrickson WA. 2012. Structure and design of broadlyneutralizing antibodies against HIV. Mol. Cells 34:231-237.
    • (2012) Mol. Cells , vol.34 , pp. 231-237
    • Ryu, S.E.1    Hendrickson, W.A.2
  • 21
    • 69149083668 scopus 로고    scopus 로고
    • Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nat
    • Stamatatos L, Morris L, Burton DR, Mascola JR. 2009. Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nat. Med. 15:866-870.
    • (2009) Med. , vol.15 , pp. 866-870
    • Stamatatos, L.1    Morris, L.2    Burton, D.R.3    Mascola, J.R.4
  • 22
    • 84862732215 scopus 로고    scopus 로고
    • The design and evaluation of HIV-1 vaccines
    • Saunders KO, Rudicell RS, Nabel GJ. 2012. The design and evaluation of HIV-1 vaccines. AIDS 26:1293-1302.
    • (2012) AIDS , vol.26 , pp. 1293-1302
    • Saunders, K.O.1    Rudicell, R.S.2    Nabel, G.J.3
  • 23
    • 84860759632 scopus 로고    scopus 로고
    • B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study
    • Haynes BF, Kelsoe G, Harrison SC, Kepler TB. 2012. B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat. Biotechnol. 30:423- 433.
    • (2012) Nat. Biotechnol. , vol.30 , pp. 423-433
    • Haynes, B.F.1    Kelsoe, G.2    Harrison, S.C.3    Kepler, T.B.4
  • 25
    • 79955783725 scopus 로고    scopus 로고
    • Isolation of potent neutralizing monoclonal antibodies from an SIV-Infected rhesus macaque by phage display
    • Kuwata T, Katsumata Y, Takaki K, Miura T, Igarashi T. 2011. Isolation of potent neutralizing monoclonal antibodies from an SIV-Infected rhesus macaque by phage display. AIDS Res. Hum. Retroviruses 27:487-500.
    • (2011) AIDS Res. Hum. Retroviruses , vol.27 , pp. 487-500
    • Kuwata, T.1    Katsumata, Y.2    Takaki, K.3    Miura, T.4    Igarashi, T.5
  • 26
    • 34548183743 scopus 로고    scopus 로고
    • A rapid progressor-specific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses
    • Kuwata T, Byrum R, Whitted S, Goeken R, Buckler-White A, Plishka R, Iyengar R, Hirsch VM. 2007. A rapid progressor-specific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses. J. Virol. 81:8891- 8904.
    • (2007) J. Virol. , vol.81 , pp. 8891-8904
    • Kuwata, T.1    Byrum, R.2    Whitted, S.3    Goeken, R.4    Buckler-White, A.5    Plishka, R.6    Iyengar, R.7    Hirsch, V.M.8
  • 27
    • 31144431607 scopus 로고    scopus 로고
    • Infectious molecular clones from a simian immunodeficiency virus-infected rapidprogressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo
    • Kuwata T, Dehghani H, Brown CR, Plishka R, Buckler-White A, Igarashi T, Mattapallil J, Roederer M, Hirsch VM. 2006. Infectious molecular clones from a simian immunodeficiency virus-infected rapidprogressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo. J. Virol. 80:1463-1475.
    • (2006) J. Virol. , vol.80 , pp. 1463-1475
    • Kuwata, T.1    Dehghani, H.2    Brown, C.R.3    Plishka, R.4    Buckler-White, A.5    Igarashi, T.6    Mattapallil, J.7    Roederer, M.8    Hirsch, V.M.9
  • 28
    • 0029063578 scopus 로고
    • Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4 T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1
    • Lusso P, Cocchi F, Balotta C, Markham PD, Louie A, Farci P, Pal R, Gallo RC, Reitz MS, Jr. 1995. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4 T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J. Virol. 69:3712-3720.
    • (1995) J. Virol. , vol.69 , pp. 3712-3720
    • Lusso, P.1    Cocchi, F.2    Balotta, C.3    Markham, P.D.4    Louie, A.5    Farci, P.6    Pal, R.7    Gallo, R.C.8    Reitz, M.S.Jr.9
  • 29
    • 24044454355 scopus 로고    scopus 로고
    • Isolation of TAK-779-resistant HIV-1 from an R5 HIV-1 GP120 V3 loop library
    • Yusa K, Maeda Y, Fujioka A, Monde K, Harada S. 2005. Isolation of TAK-779-resistant HIV-1 from an R5 HIV-1 GP120 V3 loop library. J. Biol. Chem. 280:30083-30090.
    • (2005) J. Biol. Chem. , vol.280 , pp. 30083-30090
    • Yusa, K.1    Maeda, Y.2    Fujioka, A.3    Monde, K.4    Harada, S.5
  • 30
    • 57349139455 scopus 로고    scopus 로고
    • Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research
    • Takeuchi Y, McClure MO, Pizzato M. 2008. Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. J. Virol. 82:12585-12588.
    • (2008) J. Virol. , vol.82 , pp. 12585-12588
    • Takeuchi, Y.1    McClure, M.O.2    Pizzato, M.3
  • 32
    • 0033856458 scopus 로고    scopus 로고
    • Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120
    • Derdeyn CA, Decker JM, Sfakianos JN, Wu X, O'Brien WA, Ratner L, Kappes JC, Shaw GM, Hunter E. 2000. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74:8358-8367.
    • (2000) J. Virol. , vol.74 , pp. 8358-8367
    • Derdeyn, C.A.1    Decker, J.M.2    Sfakianos, J.N.3    Wu, X.4    O'Brien, W.A.5    Ratner, L.6    Kappes, J.C.7    Shaw, G.M.8    Hunter, E.9
  • 33
    • 0031954686 scopus 로고    scopus 로고
    • Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1
    • Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D. 1998. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72: 2855-2864.
    • (1998) J. Virol. , vol.72 , pp. 2855-2864
    • Platt, E.J.1    Wehrly, K.2    Kuhmann, S.E.3    Chesebro, B.4    Kabat, D.5
  • 37
    • 0026561511 scopus 로고
    • Complex determinants of macrophage tropism in env of simian immunodeficiency virus
    • Mori K, Ringler DJ, Kodama T, Desrosiers RC. 1992. Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J. Virol. 66:2067-2075.
    • (1992) J. Virol. , vol.66 , pp. 2067-2075
    • Mori, K.1    Ringler, D.J.2    Kodama, T.3    Desrosiers, R.C.4
  • 40
    • 0003400039 scopus 로고    scopus 로고
    • Phage display: a laboratory manual
    • Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
    • Barbas CF, Scott JM, Silverman G, Burton DR. 2001. Phage display: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
    • (2001)
    • Barbas, C.F.1    Scott, J.M.2    Silverman, G.3    Burton, D.R.4
  • 41
    • 0025008099 scopus 로고
    • Anovel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter wells coated with concanavalin A
    • Robinson JE, Holton D, Liu J, McMurdo H, Murciano A, Gohd R. 1990. Anovel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter wells coated with concanavalin A. J. Immunol. Methods 132:63-71.
    • (1990) J. Immunol. Methods , vol.132 , pp. 63-71
    • Robinson, J.E.1    Holton, D.2    Liu, J.3    McMurdo, H.4    Murciano, A.5    Gohd, R.6
  • 42
    • 34247213249 scopus 로고    scopus 로고
    • Contribution of monocytes to viral replication in macaques during acute infection with simian immunodeficiency virus
    • Kuwata T, Kodama M, Sato A, Suzuki H, Miyazaki Y, Miura T, Hayami M. 2007. Contribution of monocytes to viral replication in macaques during acute infection with simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 23:372-380.
    • (2007) AIDS Res. Hum. Retroviruses , vol.23 , pp. 372-380
    • Kuwata, T.1    Kodama, M.2    Sato, A.3    Suzuki, H.4    Miyazaki, Y.5    Miura, T.6    Hayami, M.7
  • 44
    • 0025253819 scopus 로고
    • Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding
    • Olshevsky U, Helseth E, Furman C, Li J, Haseltine W, Sodroski J. 1990. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64:5701-5707.
    • (1990) J. Virol. , vol.64 , pp. 5701-5707
    • Olshevsky, U.1    Helseth, E.2    Furman, C.3    Li, J.4    Haseltine, W.5    Sodroski, J.6
  • 45
    • 77958115264 scopus 로고    scopus 로고
    • A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals
    • doi:10.1371/journal.ppat.1001028.
    • Walker LM, Simek MD, Priddy F, Gach JS, Wagner D, Zwick MB, Phogat SK, Poignard P, Burton DR. 2010. A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals. PLoS Pathog. 6:e1001028. doi:10.1371 /journal.ppat.1001028.
    • (2010) PLoS Pathog. , vol.6
    • Walker, L.M.1    Simek, M.D.2    Priddy, F.3    Gach, J.S.4    Wagner, D.5    Zwick, M.B.6    Phogat, S.K.7    Poignard, P.8    Burton, D.R.9
  • 46
    • 0027256814 scopus 로고
    • Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120- CD4 binding
    • Thali M, Moore JP, Furman C, Charles M, Ho DD, Robinson J, Sodroski J. 1993. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120- CD4 binding. J. Virol. 67:3978 -3988.
    • (1993) J. Virol. , vol.67 , pp. 3978-3988
    • Thali, M.1    Moore, J.P.2    Furman, C.3    Charles, M.4    Ho, D.D.5    Robinson, J.6    Sodroski, J.7
  • 47
    • 0026753062 scopus 로고
    • Identification of two neutralizing and 8 nonneutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies
    • Kent KA, Rud E, Corcoran T, Powell C, Thiriart C, Collignon C, Stott EJ. 1992. Identification of two neutralizing and 8 nonneutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Res. Hum. Retroviruses 8:1147-1151.
    • (1992) AIDS Res. Hum. Retroviruses , vol.8 , pp. 1147-1151
    • Kent, K.A.1    Rud, E.2    Corcoran, T.3    Powell, C.4    Thiriart, C.5    Collignon, C.6    Stott, E.J.7
  • 48
    • 77951039586 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 evasion of a neutralizing anti-V3 antibody involves acquisition of a potential glycosylation site in V2
    • Hatada M, Yoshimura K, Harada S, Kawanami Y, Shibata J, Matsushita S. 2010. Human immunodeficiency virus type 1 evasion of a neutralizing anti-V3 antibody involves acquisition of a potential glycosylation site in V2. J. Gen. Virol. 91:1335-1345.
    • (2010) J. Gen. Virol. , vol.91 , pp. 1335-1345
    • Hatada, M.1    Yoshimura, K.2    Harada, S.3    Kawanami, Y.4    Shibata, J.5    Matsushita, S.6
  • 49
    • 33750263710 scopus 로고    scopus 로고
    • Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors
    • Yoshimura K, Shibata J, Kimura T, Honda A, Maeda Y, Koito A, Murakami T, Mitsuya H, Matsushita S. 2006. Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors. AIDS. 20:2065-2073.
    • (2006) AIDS. , vol.20 , pp. 2065-2073
    • Yoshimura, K.1    Shibata, J.2    Kimura, T.3    Honda, A.4    Maeda, Y.5    Koito, A.6    Murakami, T.7    Mitsuya, H.8    Matsushita, S.9
  • 52
    • 79957613599 scopus 로고    scopus 로고
    • MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods
    • Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739.
    • (2011) Mol. Biol. Evol. , vol.28 , pp. 2731-2739
    • Tamura, K.1    Peterson, D.2    Peterson, N.3    Stecher, G.4    Nei, M.5    Kumar, S.6
  • 53
    • 84862095730 scopus 로고    scopus 로고
    • Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop
    • doi:10.1371/journal.pone.0037530.
    • Yokoyama M, Naganawa S, Yoshimura K, Matsushita S, Sato H. 2012. Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop. PLoS One 7:e37530. doi:10.1371/journal.pone.0037530.
    • (2012) PLoS One , vol.7
    • Yokoyama, M.1    Naganawa, S.2    Yoshimura, K.3    Matsushita, S.4    Sato, H.5
  • 55
    • 63149160656 scopus 로고    scopus 로고
    • Structural improvement of unliganded simian immunodeficiency virus gp120 core by normalmode- based X-ray crystallographic refinement
    • Chen X, Lu M, Poon BK, Wang Q, Ma J. 2009. Structural improvement of unliganded simian immunodeficiency virus gp120 core by normalmode- based X-ray crystallographic refinement. Acta Crystallogr. D Biol. Crystallogr. 65:339 -347.
    • (2009) Acta Crystallogr. D Biol. Crystallogr. , vol.65 , pp. 339-347
    • Chen, X.1    Lu, M.2    Poon, B.K.3    Wang, Q.4    Ma, J.5
  • 56
    • 84862685920 scopus 로고    scopus 로고
    • GLYCAM web. Complex Carbohydrate Research Center
    • University of Georgia, Athens, GA.
    • Group W. 2005. GLYCAM web. Complex Carbohydrate Research Center, University of Georgia, Athens, GA.
    • (2005)
    • Group, W.1
  • 58
    • 0029633186 scopus 로고
    • AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules
    • Pearlman DA, Case DA, Caldwell JW, Ross WS, Cheatham Iii TE, DeBolt S, Ferguson D, Seibel G, Kollman P. 1995. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comput. Phys. Commun. 91:1- 41.
    • (1995) Comput. Phys. Commun. , vol.91
    • Pearlman, D.A.1    Case, D.A.2    Caldwell, J.W.3    Ross, W.S.4    Cheatham Iii, T.E.5    DeBolt, S.6    Ferguson, D.7    Seibel, G.8    Kollman, P.9
  • 59
    • 33748518255 scopus 로고    scopus 로고
    • Comparison of multiple Amber force fields and development of improved protein backbone parameters
    • Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C. 2006. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 65:712-725.
    • (2006) Proteins , vol.65 , pp. 712-725
    • Hornak, V.1    Abel, R.2    Okur, A.3    Strockbine, B.4    Roitberg, A.5    Simmerling, C.6
  • 62
    • 33646940952 scopus 로고
    • Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes
    • Ryckaert J-P, Ciccotti G, Berendsen HJC. 1977. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Physics 23:327-341.
    • (1977) J. Comput. Physics , vol.23 , pp. 327-341
    • Ryckaert, J.-P.1    Ciccotti, G.2    Berendsen, H.J.C.3
  • 65
    • 77954525340 scopus 로고    scopus 로고
    • Enhanced exposure of human immunodeficiency virus type 1 primary isolate neutralization epitopes through binding of CD4 mimetic compounds
    • Yoshimura K, Harada S, Shibata J, Hatada M, Yamada Y, Ochiai C, Tamamura H, Matsushita S. 2010. Enhanced exposure of human immunodeficiency virus type 1 primary isolate neutralization epitopes through binding of CD4 mimetic compounds. J. Virol. 84:7558 -7568.
    • (2010) J. Virol. , vol.84 , pp. 7558-7568
    • Yoshimura, K.1    Harada, S.2    Shibata, J.3    Hatada, M.4    Yamada, Y.5    Ochiai, C.6    Tamamura, H.7    Matsushita, S.8
  • 67
    • 0031964765 scopus 로고    scopus 로고
    • Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque
    • Glamann J, Burton DR, Parren PW, Ditzel HJ, Kent KA, Arnold C, Montefiori D, Hirsch VM. 1998. Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque. J. Virol. 72:585-592.
    • (1998) J. Virol. , vol.72 , pp. 585-592
    • Glamann, J.1    Burton, D.R.2    Parren, P.W.3    Ditzel, H.J.4    Kent, K.A.5    Arnold, C.6    Montefiori, D.7    Hirsch, V.M.8
  • 68
    • 0033894950 scopus 로고    scopus 로고
    • Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein
    • Edinger AL, Ahuja M, Sung T, Baxter KC, Haggarty B, Doms RW, Hoxie JA. 2000. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein. J. Virol. 74:7922-7935.
    • (2000) J. Virol. , vol.74 , pp. 7922-7935
    • Edinger, A.L.1    Ahuja, M.2    Sung, T.3    Baxter, K.C.4    Haggarty, B.5    Doms, R.W.6    Hoxie, J.A.7
  • 71
    • 70449701456 scopus 로고    scopus 로고
    • Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens
    • Xiao X, Chen W, Feng Y, Zhu Z, Prabakaran P, Wang Y, Zhang MY, Longo NS, Dimitrov DS. 2009. Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens. Biochem. Biophys. Res. Commun. 390:404-409.
    • (2009) Biochem. Biophys. Res. Commun. , vol.390 , pp. 404-409
    • Xiao, X.1    Chen, W.2    Feng, Y.3    Zhu, Z.4    Prabakaran, P.5    Wang, Y.6    Zhang, M.Y.7    Longo, N.S.8    Dimitrov, D.S.9
  • 72
    • 84862777880 scopus 로고    scopus 로고
    • Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: implications for mechanisms of immune evasion and design of vaccine immunogens
    • Chen W, Streaker ED, Russ DE, Feng Y, Prabakaran P, Dimitrov DS. 2012. Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: implications for mechanisms of immune evasion and design of vaccine immunogens. Biochem. Biophys. Res. Commun. 417: 1164-1169.
    • (2012) Biochem. Biophys. Res. Commun. , vol.417 , pp. 1164-1169
    • Chen, W.1    Streaker, E.D.2    Russ, D.E.3    Feng, Y.4    Prabakaran, P.5    Dimitrov, D.S.6
  • 73
    • 77949411309 scopus 로고    scopus 로고
    • Quaternary epitope specificities of anti-HIV-1 neutralizing antibodies generated in rhesus macaques infected by the simian/human immunodeficiency virus SHIVSF162P4
    • Robinson JE, Franco K, Elliott DH, Maher MJ, Reyna A, Montefiori DC, Zolla-Pazner S, Gorny MK, Kraft Z, Stamatatos L. 2010. Quaternary epitope specificities of anti-HIV-1 neutralizing antibodies generated in rhesus macaques infected by the simian/human immunodeficiency virus SHIVSF162P4. J. Virol. 84:3443-3453.
    • (2010) J. Virol. , vol.84 , pp. 3443-3453
    • Robinson, J.E.1    Franco, K.2    Elliott, D.H.3    Maher, M.J.4    Reyna, A.5    Montefiori, D.C.6    Zolla-Pazner, S.7    Gorny, M.K.8    Kraft, Z.9    Stamatatos, L.10
  • 74
    • 80052314665 scopus 로고    scopus 로고
    • Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: differences from the human counterparts and implications for HIV-1 vaccine development
    • Yuan T, Li J, Zhang Y, Wang Y, Streaker E, Dimitrov DS, Zhang M-Y. 2011. Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: differences from the human counterparts and implications for HIV-1 vaccine development. Vaccine 29:6903- 6910.
    • (2011) Vaccine , vol.29 , pp. 6903-6910
    • Yuan, T.1    Li, J.2    Zhang, Y.3    Wang, Y.4    Streaker, E.5    Dimitrov, D.S.6    Zhang, M.-Y.7
  • 75
    • 16844386973 scopus 로고    scopus 로고
    • Despite extensive similarity in germline DH and JH sequence the adult rhesus macaque CDR-H3 repertoire differs from human
    • Link JM, Larson JE, Schroeder HW. 2005. Despite extensive similarity in germline DH and JH sequence, the adult rhesus macaque CDR-H3 repertoire differs from human. Mol. Immunol. 42:943-955.
    • (2005) Mol. Immunol. , vol.42 , pp. 943-955
    • Link, J.M.1    Larson, J.E.2    Schroeder, H.W.3
  • 77
    • 84862681126 scopus 로고    scopus 로고
    • Naturally occurring substitutions of conserved residues in human immunodeficiency virus type 1 variants of different clades are involved in PG9 and PG16 resistance to neutralization
    • Thenin S, Roch E, Samleerat T, Moreau T, Chaillon A, Moreau A, Barin F, Braibant M. 2012. Naturally occurring substitutions of conserved residues in human immunodeficiency virus type 1 variants of different clades are involved in PG9 and PG16 resistance to neutralization. J. Virol. 93: 1495-1505.
    • (2012) J. Virol. , vol.93 , pp. 1495-1505
    • Thenin, S.1    Roch, E.2    Samleerat, T.3    Moreau, T.4    Chaillon, A.5    Moreau, A.6    Barin, F.7    Braibant, M.8
  • 78
    • 77950816445 scopus 로고    scopus 로고
    • Two Nlinked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain
    • Utachee P, Nakamura S, Isarangkura-Na-Ayuthaya P, Tokunaga K, Sawanpanyalert P, Ikuta K, Auwanit W, Kameoka M. 2010. Two Nlinked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain. J. Virol. 84:4311- 4320.
    • (2010) J. Virol. , vol.84 , pp. 4311-4320
    • Utachee, P.1    Nakamura, S.2    Isarangkura-Na-Ayuthaya, P.3    Tokunaga, K.4    Sawanpanyalert, P.5    Ikuta, K.6    Auwanit, W.7    Kameoka, M.8
  • 79
    • 37249032102 scopus 로고    scopus 로고
    • Dynamic personalities of proteins
    • Henzler-Wildman K, Kern D. 2007. Dynamic personalities of proteins. Nature 450:964 -972.
    • (2007) Nature , vol.450 , pp. 964-972
    • Henzler-Wildman, K.1    Kern, D.2
  • 83
    • 38749096240 scopus 로고    scopus 로고
    • The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
    • Sekaly RP. 2008. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J. Exp. Med. 205:7-12.
    • (2008) J. Exp. Med. , vol.205 , pp. 7-12
    • Sekaly, R.P.1
  • 84
    • 44949100369 scopus 로고    scopus 로고
    • Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans
    • Watkins DI, Burton DR, Kallas EG, Moore JP, Koff WC. 2008. Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans. Nat. Med. 14:617- 621.
    • (2008) Nat. Med. , vol.14 , pp. 617-621
    • Watkins, D.I.1    Burton, D.R.2    Kallas, E.G.3    Moore, J.P.4    Koff, W.C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.